Global Tafasitamab Supply, Demand and Key Producers, 2026-2032
The global Tafasitamab market size is expected to reach $ 812 million by 2032, rising at a market growth of 11.5% CAGR during the forecast period (2026-2032).
Tafasitamab is a humanized CD19-targeted monoclonal antibody primarily used in the treatment of B-cell malignancies. It specifically binds to the CD19 antigen expressed on the surface of B cells, inducing antibody-dependent cellular cytotoxicity (ADCC) and other immune-mediated mechanisms, thereby promoting the elimination of malignant B cells. Tafasitamab is typically used in combination with immunomodulatory agents such as lenalidomide for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It has significant clinical value in the field of hematologic cancer targeted therapy.In 2025, global production of tafasitamab reached approximately 150,000units.
Tafasitamab, as a CD19-targeted monoclonal antibody, occupies an important niche in the treatment market for B-cell non-Hodgkin lymphoma, particularly in relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). With the steady increase in the global incidence of hematologic malignancies and the growing demand for novel immuno-targeted therapies, the CD19-targeted drug market is gradually expanding. Tafasitamab has demonstrated clinical efficacy in combination with lenalidomide, enabling it to gain guideline recommendations and improve its clinical penetration. From a competitive landscape perspective, this field is not only dominated by long-established CD20 monoclonal antibodies such as rituximab, but also faces competitive pressure from emerging CD19/CD79b-targeted therapies. Looking ahead, with the accumulation of real-world evidence, expansion of indications, and commercialization in emerging markets, the market size of tafasitamab is expected to maintain steady growth, continuing to play an important role in the precision treatment landscape of B-cell lymphoma.
This report studies the global Tafasitamab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tafasitamab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tafasitamab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tafasitamab total production and demand, 2021-2032, (Units)
Global Tafasitamab total production value, 2021-2032, (USD Million)
Global Tafasitamab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Tafasitamab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Tafasitamab domestic production, consumption, key domestic manufacturers and share
Global Tafasitamab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Tafasitamab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Tafasitamab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Tafasitamab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MorphoSys AG, Incyte Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tafasitamab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Tafasitamab Market, By Region:
1. How big is the global Tafasitamab market?
2. What is the demand of the global Tafasitamab market?
3. What is the year over year growth of the global Tafasitamab market?
4. What is the production and production value of the global Tafasitamab market?
5. Who are the key producers in the global Tafasitamab market?
6. What are the growth factors driving the market demand?
Tafasitamab is a humanized CD19-targeted monoclonal antibody primarily used in the treatment of B-cell malignancies. It specifically binds to the CD19 antigen expressed on the surface of B cells, inducing antibody-dependent cellular cytotoxicity (ADCC) and other immune-mediated mechanisms, thereby promoting the elimination of malignant B cells. Tafasitamab is typically used in combination with immunomodulatory agents such as lenalidomide for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It has significant clinical value in the field of hematologic cancer targeted therapy.In 2025, global production of tafasitamab reached approximately 150,000units.
Tafasitamab, as a CD19-targeted monoclonal antibody, occupies an important niche in the treatment market for B-cell non-Hodgkin lymphoma, particularly in relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). With the steady increase in the global incidence of hematologic malignancies and the growing demand for novel immuno-targeted therapies, the CD19-targeted drug market is gradually expanding. Tafasitamab has demonstrated clinical efficacy in combination with lenalidomide, enabling it to gain guideline recommendations and improve its clinical penetration. From a competitive landscape perspective, this field is not only dominated by long-established CD20 monoclonal antibodies such as rituximab, but also faces competitive pressure from emerging CD19/CD79b-targeted therapies. Looking ahead, with the accumulation of real-world evidence, expansion of indications, and commercialization in emerging markets, the market size of tafasitamab is expected to maintain steady growth, continuing to play an important role in the precision treatment landscape of B-cell lymphoma.
This report studies the global Tafasitamab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tafasitamab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tafasitamab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tafasitamab total production and demand, 2021-2032, (Units)
Global Tafasitamab total production value, 2021-2032, (USD Million)
Global Tafasitamab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Tafasitamab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Tafasitamab domestic production, consumption, key domestic manufacturers and share
Global Tafasitamab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Tafasitamab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Tafasitamab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Tafasitamab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MorphoSys AG, Incyte Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tafasitamab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Tafasitamab Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Combination With Immunomodulatory Agents (Such As Lenalidomide)
- Combination With Chemotherapy Or Other Targeted Therapies
- 200 mg / vial
- 800 mg/vial
- Innovator
- Generic
- Lyophilized Powder for Injection
- Injection Solution
- Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
- B-Cell Non-Hodgkin Lymphoma (B-NHL)
- CD19-Positive Hematologic Malignancies
- Precision Hematologic Cancer Therapy
- Others
- MorphoSys AG
- Incyte Corporation
1. How big is the global Tafasitamab market?
2. What is the demand of the global Tafasitamab market?
3. What is the year over year growth of the global Tafasitamab market?
4. What is the production and production value of the global Tafasitamab market?
5. Who are the key producers in the global Tafasitamab market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tafasitamab Introduction
1.2 World Tafasitamab Supply & Forecast
1.2.1 World Tafasitamab Production Value (2021 & 2025 & 2032)
1.2.2 World Tafasitamab Production (2021-2032)
1.2.3 World Tafasitamab Pricing Trends (2021-2032)
1.3 World Tafasitamab Production by Region (Based on Production Site)
1.3.1 World Tafasitamab Production Value by Region (2021-2032)
1.3.2 World Tafasitamab Production by Region (2021-2032)
1.3.3 World Tafasitamab Average Price by Region (2021-2032)
1.3.4 North America Tafasitamab Production (2021-2032)
1.3.5 Europe Tafasitamab Production (2021-2032)
1.3.6 China Tafasitamab Production (2021-2032)
1.3.7 Japan Tafasitamab Production (2021-2032)
1.3.8 India Tafasitamab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tafasitamab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tafasitamab Major Market Trends
2 DEMAND SUMMARY
2.1 World Tafasitamab Demand (2021-2032)
2.2 World Tafasitamab Consumption by Region
2.2.1 World Tafasitamab Consumption by Region (2021-2026)
2.2.2 World Tafasitamab Consumption Forecast by Region (2027-2032)
2.3 United States Tafasitamab Consumption (2021-2032)
2.4 China Tafasitamab Consumption (2021-2032)
2.5 Europe Tafasitamab Consumption (2021-2032)
2.6 Japan Tafasitamab Consumption (2021-2032)
2.7 South Korea Tafasitamab Consumption (2021-2032)
2.8 ASEAN Tafasitamab Consumption (2021-2032)
2.9 India Tafasitamab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Tafasitamab Production Value by Manufacturer (2021-2026)
3.2 World Tafasitamab Production by Manufacturer (2021-2026)
3.3 World Tafasitamab Average Price by Manufacturer (2021-2026)
3.4 Tafasitamab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tafasitamab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tafasitamab in 2025
3.5.3 Global Concentration Ratios (CR8) for Tafasitamab in 2025
3.6 Tafasitamab Market: Overall Company Footprint Analysis
3.6.1 Tafasitamab Market: Region Footprint
3.6.2 Tafasitamab Market: Company Product Type Footprint
3.6.3 Tafasitamab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Tafasitamab Production Value Comparison
4.1.1 United States VS China: Tafasitamab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Tafasitamab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Tafasitamab Production Comparison
4.2.1 United States VS China: Tafasitamab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Tafasitamab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Tafasitamab Consumption Comparison
4.3.1 United States VS China: Tafasitamab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Tafasitamab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Tafasitamab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Tafasitamab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tafasitamab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Tafasitamab Production (2021-2026)
4.5 China Based Tafasitamab Manufacturers and Market Share
4.5.1 China Based Tafasitamab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tafasitamab Production Value (2021-2026)
4.5.3 China Based Manufacturers Tafasitamab Production (2021-2026)
4.6 Rest of World Based Tafasitamab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Tafasitamab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tafasitamab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Tafasitamab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Tafasitamab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Combination With Immunomodulatory Agents (Such As Lenalidomide)
5.2.2 Combination With Chemotherapy Or Other Targeted Therapies
5.3 Market Segment by Type
5.3.1 World Tafasitamab Production by Type (2021-2032)
5.3.2 World Tafasitamab Production Value by Type (2021-2032)
5.3.3 World Tafasitamab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPECIFICATION
6.1 World Tafasitamab Market Size Overview by Specification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Specification
6.2.1 200 mg / vial
6.2.2 800 mg/vial
6.3 Market Segment by Specification
6.3.1 World Tafasitamab Production by Specification (2021-2032)
6.3.2 World Tafasitamab Production Value by Specification (2021-2032)
6.3.3 World Tafasitamab Average Price by Specification (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Tafasitamab Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Production Technology
7.3.1 World Tafasitamab Production by Production Technology (2021-2032)
7.3.2 World Tafasitamab Production Value by Production Technology (2021-2032)
7.3.3 World Tafasitamab Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORM
8.1 World Tafasitamab Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Form
8.2.1 Lyophilized Powder for Injection
8.2.2 Injection Solution
8.3 Market Segment by Dosage Form
8.3.1 World Tafasitamab Production by Dosage Form (2021-2032)
8.3.2 World Tafasitamab Production Value by Dosage Form (2021-2032)
8.3.3 World Tafasitamab Average Price by Dosage Form (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Tafasitamab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
9.2.2 B-Cell Non-Hodgkin Lymphoma (B-NHL)
9.2.3 CD19-Positive Hematologic Malignancies
9.2.4 Precision Hematologic Cancer Therapy
9.2.5 Others
9.3 Market Segment by Application
9.3.1 World Tafasitamab Production by Application (2021-2032)
9.3.2 World Tafasitamab Production Value by Application (2021-2032)
9.3.3 World Tafasitamab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 MorphoSys AG
10.1.1 MorphoSys AG Details
10.1.2 MorphoSys AG Major Business
10.1.3 MorphoSys AG Tafasitamab Product and Services
10.1.4 MorphoSys AG Tafasitamab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 MorphoSys AG Recent Developments/Updates
10.1.6 MorphoSys AG Competitive Strengths & Weaknesses
10.2 Incyte Corporation
10.2.1 Incyte Corporation Details
10.2.2 Incyte Corporation Major Business
10.2.3 Incyte Corporation Tafasitamab Product and Services
10.2.4 Incyte Corporation Tafasitamab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Incyte Corporation Recent Developments/Updates
10.2.6 Incyte Corporation Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Tafasitamab Industry Chain
11.2 Tafasitamab Upstream Analysis
11.2.1 Tafasitamab Core Raw Materials
11.2.2 Main Manufacturers of Tafasitamab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Tafasitamab Production Mode
11.6 Tafasitamab Procurement Model
11.7 Tafasitamab Industry Sales Model and Sales Channels
11.7.1 Tafasitamab Sales Model
11.7.2 Tafasitamab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Tafasitamab Introduction
1.2 World Tafasitamab Supply & Forecast
1.2.1 World Tafasitamab Production Value (2021 & 2025 & 2032)
1.2.2 World Tafasitamab Production (2021-2032)
1.2.3 World Tafasitamab Pricing Trends (2021-2032)
1.3 World Tafasitamab Production by Region (Based on Production Site)
1.3.1 World Tafasitamab Production Value by Region (2021-2032)
1.3.2 World Tafasitamab Production by Region (2021-2032)
1.3.3 World Tafasitamab Average Price by Region (2021-2032)
1.3.4 North America Tafasitamab Production (2021-2032)
1.3.5 Europe Tafasitamab Production (2021-2032)
1.3.6 China Tafasitamab Production (2021-2032)
1.3.7 Japan Tafasitamab Production (2021-2032)
1.3.8 India Tafasitamab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tafasitamab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tafasitamab Major Market Trends
2 DEMAND SUMMARY
2.1 World Tafasitamab Demand (2021-2032)
2.2 World Tafasitamab Consumption by Region
2.2.1 World Tafasitamab Consumption by Region (2021-2026)
2.2.2 World Tafasitamab Consumption Forecast by Region (2027-2032)
2.3 United States Tafasitamab Consumption (2021-2032)
2.4 China Tafasitamab Consumption (2021-2032)
2.5 Europe Tafasitamab Consumption (2021-2032)
2.6 Japan Tafasitamab Consumption (2021-2032)
2.7 South Korea Tafasitamab Consumption (2021-2032)
2.8 ASEAN Tafasitamab Consumption (2021-2032)
2.9 India Tafasitamab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Tafasitamab Production Value by Manufacturer (2021-2026)
3.2 World Tafasitamab Production by Manufacturer (2021-2026)
3.3 World Tafasitamab Average Price by Manufacturer (2021-2026)
3.4 Tafasitamab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tafasitamab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tafasitamab in 2025
3.5.3 Global Concentration Ratios (CR8) for Tafasitamab in 2025
3.6 Tafasitamab Market: Overall Company Footprint Analysis
3.6.1 Tafasitamab Market: Region Footprint
3.6.2 Tafasitamab Market: Company Product Type Footprint
3.6.3 Tafasitamab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Tafasitamab Production Value Comparison
4.1.1 United States VS China: Tafasitamab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Tafasitamab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Tafasitamab Production Comparison
4.2.1 United States VS China: Tafasitamab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Tafasitamab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Tafasitamab Consumption Comparison
4.3.1 United States VS China: Tafasitamab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Tafasitamab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Tafasitamab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Tafasitamab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tafasitamab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Tafasitamab Production (2021-2026)
4.5 China Based Tafasitamab Manufacturers and Market Share
4.5.1 China Based Tafasitamab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tafasitamab Production Value (2021-2026)
4.5.3 China Based Manufacturers Tafasitamab Production (2021-2026)
4.6 Rest of World Based Tafasitamab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Tafasitamab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tafasitamab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Tafasitamab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Tafasitamab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Combination With Immunomodulatory Agents (Such As Lenalidomide)
5.2.2 Combination With Chemotherapy Or Other Targeted Therapies
5.3 Market Segment by Type
5.3.1 World Tafasitamab Production by Type (2021-2032)
5.3.2 World Tafasitamab Production Value by Type (2021-2032)
5.3.3 World Tafasitamab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPECIFICATION
6.1 World Tafasitamab Market Size Overview by Specification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Specification
6.2.1 200 mg / vial
6.2.2 800 mg/vial
6.3 Market Segment by Specification
6.3.1 World Tafasitamab Production by Specification (2021-2032)
6.3.2 World Tafasitamab Production Value by Specification (2021-2032)
6.3.3 World Tafasitamab Average Price by Specification (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Tafasitamab Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Production Technology
7.3.1 World Tafasitamab Production by Production Technology (2021-2032)
7.3.2 World Tafasitamab Production Value by Production Technology (2021-2032)
7.3.3 World Tafasitamab Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORM
8.1 World Tafasitamab Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Form
8.2.1 Lyophilized Powder for Injection
8.2.2 Injection Solution
8.3 Market Segment by Dosage Form
8.3.1 World Tafasitamab Production by Dosage Form (2021-2032)
8.3.2 World Tafasitamab Production Value by Dosage Form (2021-2032)
8.3.3 World Tafasitamab Average Price by Dosage Form (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Tafasitamab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
9.2.2 B-Cell Non-Hodgkin Lymphoma (B-NHL)
9.2.3 CD19-Positive Hematologic Malignancies
9.2.4 Precision Hematologic Cancer Therapy
9.2.5 Others
9.3 Market Segment by Application
9.3.1 World Tafasitamab Production by Application (2021-2032)
9.3.2 World Tafasitamab Production Value by Application (2021-2032)
9.3.3 World Tafasitamab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 MorphoSys AG
10.1.1 MorphoSys AG Details
10.1.2 MorphoSys AG Major Business
10.1.3 MorphoSys AG Tafasitamab Product and Services
10.1.4 MorphoSys AG Tafasitamab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 MorphoSys AG Recent Developments/Updates
10.1.6 MorphoSys AG Competitive Strengths & Weaknesses
10.2 Incyte Corporation
10.2.1 Incyte Corporation Details
10.2.2 Incyte Corporation Major Business
10.2.3 Incyte Corporation Tafasitamab Product and Services
10.2.4 Incyte Corporation Tafasitamab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Incyte Corporation Recent Developments/Updates
10.2.6 Incyte Corporation Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Tafasitamab Industry Chain
11.2 Tafasitamab Upstream Analysis
11.2.1 Tafasitamab Core Raw Materials
11.2.2 Main Manufacturers of Tafasitamab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Tafasitamab Production Mode
11.6 Tafasitamab Procurement Model
11.7 Tafasitamab Industry Sales Model and Sales Channels
11.7.1 Tafasitamab Sales Model
11.7.2 Tafasitamab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Tafasitamab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Tafasitamab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Tafasitamab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Tafasitamab Production Value Market Share by Region (2021-2026)
Table 5. World Tafasitamab Production Value Market Share by Region (2027-2032)
Table 6. World Tafasitamab Production by Region (2021-2026) & (Units)
Table 7. World Tafasitamab Production by Region (2027-2032) & (Units)
Table 8. World Tafasitamab Production Market Share by Region (2021-2026)
Table 9. World Tafasitamab Production Market Share by Region (2027-2032)
Table 10. World Tafasitamab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Tafasitamab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Tafasitamab Major Market Trends
Table 13. World Tafasitamab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Tafasitamab Consumption by Region (2021-2026) & (Units)
Table 15. World Tafasitamab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Tafasitamab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Tafasitamab Producers in 2025
Table 18. World Tafasitamab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Tafasitamab Producers in 2025
Table 20. World Tafasitamab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Tafasitamab Company Evaluation Quadrant
Table 22. World Tafasitamab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Tafasitamab Production Site of Key Manufacturer
Table 24. Tafasitamab Market: Company Product Type Footprint
Table 25. Tafasitamab Market: Company Product Application Footprint
Table 26. Tafasitamab Competitive Factors
Table 27. Tafasitamab New Entrant and Capacity Expansion Plans
Table 28. Tafasitamab Mergers & Acquisitions Activity
Table 29. United States VS China Tafasitamab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Tafasitamab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Tafasitamab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Tafasitamab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tafasitamab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Tafasitamab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Tafasitamab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Tafasitamab Production Market Share (2021-2026)
Table 37. China Based Tafasitamab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tafasitamab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Tafasitamab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Tafasitamab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Tafasitamab Production Market Share (2021-2026)
Table 42. Rest of World Based Tafasitamab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Tafasitamab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Tafasitamab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Tafasitamab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Tafasitamab Production Market Share (2021-2026)
Table 47. World Tafasitamab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Tafasitamab Production by Type (2021-2026) & (Units)
Table 49. World Tafasitamab Production by Type (2027-2032) & (Units)
Table 50. World Tafasitamab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Tafasitamab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Tafasitamab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Tafasitamab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Tafasitamab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 55. World Tafasitamab Production by Specification (2021-2026) & (Units)
Table 56. World Tafasitamab Production by Specification (2027-2032) & (Units)
Table 57. World Tafasitamab Production Value by Specification (2021-2026) & (USD Million)
Table 58. World Tafasitamab Production Value by Specification (2027-2032) & (USD Million)
Table 59. World Tafasitamab Average Price by Specification (2021-2026) & (US$/Unit)
Table 60. World Tafasitamab Average Price by Specification (2027-2032) & (US$/Unit)
Table 61. World Tafasitamab Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World Tafasitamab Production by Production Technology (2021-2026) & (Units)
Table 63. World Tafasitamab Production by Production Technology (2027-2032) & (Units)
Table 64. World Tafasitamab Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World Tafasitamab Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World Tafasitamab Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World Tafasitamab Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World Tafasitamab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 69. World Tafasitamab Production by Dosage Form (2021-2026) & (Units)
Table 70. World Tafasitamab Production by Dosage Form (2027-2032) & (Units)
Table 71. World Tafasitamab Production Value by Dosage Form (2021-2026) & (USD Million)
Table 72. World Tafasitamab Production Value by Dosage Form (2027-2032) & (USD Million)
Table 73. World Tafasitamab Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 74. World Tafasitamab Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 75. World Tafasitamab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Tafasitamab Production by Application (2021-2026) & (Units)
Table 77. World Tafasitamab Production by Application (2027-2032) & (Units)
Table 78. World Tafasitamab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Tafasitamab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Tafasitamab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Tafasitamab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. MorphoSys AG Basic Information, Manufacturing Base and Competitors
Table 83. MorphoSys AG Major Business
Table 84. MorphoSys AG Tafasitamab Product and Services
Table 85. MorphoSys AG Tafasitamab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. MorphoSys AG Recent Developments/Updates
Table 87. MorphoSys AG Competitive Strengths & Weaknesses
Table 88. Incyte Corporation Basic Information, Manufacturing Base and Competitors
Table 89. Incyte Corporation Major Business
Table 90. Incyte Corporation Tafasitamab Product and Services
Table 91. Incyte Corporation Tafasitamab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Incyte Corporation Recent Developments/Updates
Table 93. Incyte Corporation Competitive Strengths & Weaknesses
Table 94. Global Key Players of Tafasitamab Upstream (Raw Materials)
Table 95. Global Tafasitamab Typical Customers
Table 96. Tafasitamab Typical Distributors
Table 1. World Tafasitamab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Tafasitamab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Tafasitamab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Tafasitamab Production Value Market Share by Region (2021-2026)
Table 5. World Tafasitamab Production Value Market Share by Region (2027-2032)
Table 6. World Tafasitamab Production by Region (2021-2026) & (Units)
Table 7. World Tafasitamab Production by Region (2027-2032) & (Units)
Table 8. World Tafasitamab Production Market Share by Region (2021-2026)
Table 9. World Tafasitamab Production Market Share by Region (2027-2032)
Table 10. World Tafasitamab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Tafasitamab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Tafasitamab Major Market Trends
Table 13. World Tafasitamab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Tafasitamab Consumption by Region (2021-2026) & (Units)
Table 15. World Tafasitamab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Tafasitamab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Tafasitamab Producers in 2025
Table 18. World Tafasitamab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Tafasitamab Producers in 2025
Table 20. World Tafasitamab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Tafasitamab Company Evaluation Quadrant
Table 22. World Tafasitamab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Tafasitamab Production Site of Key Manufacturer
Table 24. Tafasitamab Market: Company Product Type Footprint
Table 25. Tafasitamab Market: Company Product Application Footprint
Table 26. Tafasitamab Competitive Factors
Table 27. Tafasitamab New Entrant and Capacity Expansion Plans
Table 28. Tafasitamab Mergers & Acquisitions Activity
Table 29. United States VS China Tafasitamab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Tafasitamab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Tafasitamab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Tafasitamab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tafasitamab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Tafasitamab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Tafasitamab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Tafasitamab Production Market Share (2021-2026)
Table 37. China Based Tafasitamab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tafasitamab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Tafasitamab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Tafasitamab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Tafasitamab Production Market Share (2021-2026)
Table 42. Rest of World Based Tafasitamab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Tafasitamab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Tafasitamab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Tafasitamab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Tafasitamab Production Market Share (2021-2026)
Table 47. World Tafasitamab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Tafasitamab Production by Type (2021-2026) & (Units)
Table 49. World Tafasitamab Production by Type (2027-2032) & (Units)
Table 50. World Tafasitamab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Tafasitamab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Tafasitamab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Tafasitamab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Tafasitamab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 55. World Tafasitamab Production by Specification (2021-2026) & (Units)
Table 56. World Tafasitamab Production by Specification (2027-2032) & (Units)
Table 57. World Tafasitamab Production Value by Specification (2021-2026) & (USD Million)
Table 58. World Tafasitamab Production Value by Specification (2027-2032) & (USD Million)
Table 59. World Tafasitamab Average Price by Specification (2021-2026) & (US$/Unit)
Table 60. World Tafasitamab Average Price by Specification (2027-2032) & (US$/Unit)
Table 61. World Tafasitamab Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World Tafasitamab Production by Production Technology (2021-2026) & (Units)
Table 63. World Tafasitamab Production by Production Technology (2027-2032) & (Units)
Table 64. World Tafasitamab Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World Tafasitamab Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World Tafasitamab Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World Tafasitamab Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World Tafasitamab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 69. World Tafasitamab Production by Dosage Form (2021-2026) & (Units)
Table 70. World Tafasitamab Production by Dosage Form (2027-2032) & (Units)
Table 71. World Tafasitamab Production Value by Dosage Form (2021-2026) & (USD Million)
Table 72. World Tafasitamab Production Value by Dosage Form (2027-2032) & (USD Million)
Table 73. World Tafasitamab Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 74. World Tafasitamab Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 75. World Tafasitamab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Tafasitamab Production by Application (2021-2026) & (Units)
Table 77. World Tafasitamab Production by Application (2027-2032) & (Units)
Table 78. World Tafasitamab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Tafasitamab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Tafasitamab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Tafasitamab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. MorphoSys AG Basic Information, Manufacturing Base and Competitors
Table 83. MorphoSys AG Major Business
Table 84. MorphoSys AG Tafasitamab Product and Services
Table 85. MorphoSys AG Tafasitamab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. MorphoSys AG Recent Developments/Updates
Table 87. MorphoSys AG Competitive Strengths & Weaknesses
Table 88. Incyte Corporation Basic Information, Manufacturing Base and Competitors
Table 89. Incyte Corporation Major Business
Table 90. Incyte Corporation Tafasitamab Product and Services
Table 91. Incyte Corporation Tafasitamab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Incyte Corporation Recent Developments/Updates
Table 93. Incyte Corporation Competitive Strengths & Weaknesses
Table 94. Global Key Players of Tafasitamab Upstream (Raw Materials)
Table 95. Global Tafasitamab Typical Customers
Table 96. Tafasitamab Typical Distributors
LIST OF FIGURES
Figure 1. Tafasitamab Picture
Figure 2. World Tafasitamab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Tafasitamab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Tafasitamab Production (2021-2032) & (Units)
Figure 5. World Tafasitamab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Tafasitamab Production Value Market Share by Region (2021-2032)
Figure 7. World Tafasitamab Production Market Share by Region (2021-2032)
Figure 8. North America Tafasitamab Production (2021-2032) & (Units)
Figure 9. Europe Tafasitamab Production (2021-2032) & (Units)
Figure 10. China Tafasitamab Production (2021-2032) & (Units)
Figure 11. Japan Tafasitamab Production (2021-2032) & (Units)
Figure 12. India Tafasitamab Production (2021-2032) & (Units)
Figure 13. Tafasitamab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tafasitamab Consumption (2021-2032) & (Units)
Figure 16. World Tafasitamab Consumption Market Share by Region (2021-2032)
Figure 17. United States Tafasitamab Consumption (2021-2032) & (Units)
Figure 18. China Tafasitamab Consumption (2021-2032) & (Units)
Figure 19. Europe Tafasitamab Consumption (2021-2032) & (Units)
Figure 20. Japan Tafasitamab Consumption (2021-2032) & (Units)
Figure 21. South Korea Tafasitamab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Tafasitamab Consumption (2021-2032) & (Units)
Figure 23. India Tafasitamab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Tafasitamab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tafasitamab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tafasitamab Markets in 2025
Figure 27. United States VS China: Tafasitamab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Tafasitamab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Tafasitamab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Tafasitamab Production Market Share 2025
Figure 31. China Based Manufacturers Tafasitamab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Tafasitamab Production Market Share 2025
Figure 33. World Tafasitamab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Tafasitamab Production Value Market Share by Type in 2025
Figure 35. Combination With Immunomodulatory Agents (Such As Lenalidomide)
Figure 36. Combination With Chemotherapy Or Other Targeted Therapies
Figure 37. World Tafasitamab Production Market Share by Type (2021-2032)
Figure 38. World Tafasitamab Production Value Market Share by Type (2021-2032)
Figure 39. World Tafasitamab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Tafasitamab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Figure 41. World Tafasitamab Production Value Market Share by Specification in 2025
Figure 42. 200 mg / vial
Figure 43. 800 mg/vial
Figure 44. World Tafasitamab Production Market Share by Specification (2021-2032)
Figure 45. World Tafasitamab Production Value Market Share by Specification (2021-2032)
Figure 46. World Tafasitamab Average Price by Specification (2021-2032) & (US$/Unit)
Figure 47. World Tafasitamab Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 48. World Tafasitamab Production Value Market Share by Production Technology in 2025
Figure 49. Innovator
Figure 50. Generic
Figure 51. World Tafasitamab Production Market Share by Production Technology (2021-2032)
Figure 52. World Tafasitamab Production Value Market Share by Production Technology (2021-2032)
Figure 53. World Tafasitamab Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 54. World Tafasitamab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 55. World Tafasitamab Production Value Market Share by Dosage Form in 2025
Figure 56. Lyophilized Powder for Injection
Figure 57. Injection Solution
Figure 58. World Tafasitamab Production Market Share by Dosage Form (2021-2032)
Figure 59. World Tafasitamab Production Value Market Share by Dosage Form (2021-2032)
Figure 60. World Tafasitamab Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 61. World Tafasitamab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Tafasitamab Production Value Market Share by Application in 2025
Figure 63. Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Figure 64. B-Cell Non-Hodgkin Lymphoma (B-NHL)
Figure 65. CD19-Positive Hematologic Malignancies
Figure 66. Precision Hematologic Cancer Therapy
Figure 67. Others
Figure 68. World Tafasitamab Production Market Share by Application (2021-2032)
Figure 69. World Tafasitamab Production Value Market Share by Application (2021-2032)
Figure 70. World Tafasitamab Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. Tafasitamab Industry Chain
Figure 72. Tafasitamab Procurement Model
Figure 73. Tafasitamab Sales Model
Figure 74. Tafasitamab Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Tafasitamab Picture
Figure 2. World Tafasitamab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Tafasitamab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Tafasitamab Production (2021-2032) & (Units)
Figure 5. World Tafasitamab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Tafasitamab Production Value Market Share by Region (2021-2032)
Figure 7. World Tafasitamab Production Market Share by Region (2021-2032)
Figure 8. North America Tafasitamab Production (2021-2032) & (Units)
Figure 9. Europe Tafasitamab Production (2021-2032) & (Units)
Figure 10. China Tafasitamab Production (2021-2032) & (Units)
Figure 11. Japan Tafasitamab Production (2021-2032) & (Units)
Figure 12. India Tafasitamab Production (2021-2032) & (Units)
Figure 13. Tafasitamab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tafasitamab Consumption (2021-2032) & (Units)
Figure 16. World Tafasitamab Consumption Market Share by Region (2021-2032)
Figure 17. United States Tafasitamab Consumption (2021-2032) & (Units)
Figure 18. China Tafasitamab Consumption (2021-2032) & (Units)
Figure 19. Europe Tafasitamab Consumption (2021-2032) & (Units)
Figure 20. Japan Tafasitamab Consumption (2021-2032) & (Units)
Figure 21. South Korea Tafasitamab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Tafasitamab Consumption (2021-2032) & (Units)
Figure 23. India Tafasitamab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Tafasitamab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tafasitamab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tafasitamab Markets in 2025
Figure 27. United States VS China: Tafasitamab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Tafasitamab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Tafasitamab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Tafasitamab Production Market Share 2025
Figure 31. China Based Manufacturers Tafasitamab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Tafasitamab Production Market Share 2025
Figure 33. World Tafasitamab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Tafasitamab Production Value Market Share by Type in 2025
Figure 35. Combination With Immunomodulatory Agents (Such As Lenalidomide)
Figure 36. Combination With Chemotherapy Or Other Targeted Therapies
Figure 37. World Tafasitamab Production Market Share by Type (2021-2032)
Figure 38. World Tafasitamab Production Value Market Share by Type (2021-2032)
Figure 39. World Tafasitamab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Tafasitamab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Figure 41. World Tafasitamab Production Value Market Share by Specification in 2025
Figure 42. 200 mg / vial
Figure 43. 800 mg/vial
Figure 44. World Tafasitamab Production Market Share by Specification (2021-2032)
Figure 45. World Tafasitamab Production Value Market Share by Specification (2021-2032)
Figure 46. World Tafasitamab Average Price by Specification (2021-2032) & (US$/Unit)
Figure 47. World Tafasitamab Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 48. World Tafasitamab Production Value Market Share by Production Technology in 2025
Figure 49. Innovator
Figure 50. Generic
Figure 51. World Tafasitamab Production Market Share by Production Technology (2021-2032)
Figure 52. World Tafasitamab Production Value Market Share by Production Technology (2021-2032)
Figure 53. World Tafasitamab Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 54. World Tafasitamab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 55. World Tafasitamab Production Value Market Share by Dosage Form in 2025
Figure 56. Lyophilized Powder for Injection
Figure 57. Injection Solution
Figure 58. World Tafasitamab Production Market Share by Dosage Form (2021-2032)
Figure 59. World Tafasitamab Production Value Market Share by Dosage Form (2021-2032)
Figure 60. World Tafasitamab Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 61. World Tafasitamab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Tafasitamab Production Value Market Share by Application in 2025
Figure 63. Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Figure 64. B-Cell Non-Hodgkin Lymphoma (B-NHL)
Figure 65. CD19-Positive Hematologic Malignancies
Figure 66. Precision Hematologic Cancer Therapy
Figure 67. Others
Figure 68. World Tafasitamab Production Market Share by Application (2021-2032)
Figure 69. World Tafasitamab Production Value Market Share by Application (2021-2032)
Figure 70. World Tafasitamab Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. Tafasitamab Industry Chain
Figure 72. Tafasitamab Procurement Model
Figure 73. Tafasitamab Sales Model
Figure 74. Tafasitamab Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
